1-3 of 3
Carey Clifton
Close
Sort by
Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD
Journal: Blood
Blood (2016) 128 (22): 3438.
https://doi.org/10.1182/blood.V128.22.3438.3438
Published: 2016
Journal Articles

Follow-up in Long Term Transplant Clinic Overcomes the Barrier of Geographic Distance From Transplant Center

Brittany Knick Ragon, MD, Carey Clifton, ACNP, Bipin N. Savani, MD, Brian Engelhardt, MD, Adetola A Kassim, MD, Leigh Ann Vaughan, ACNP, Catherine Lucid, ACNP, Madan Jagasia, MBBS, MS
Journal: Blood
Blood (2012) 120 (21): 2070.
https://doi.org/10.1182/blood.V120.21.2070.2070
Published: 2012
Journal Articles

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

Carey Clifton, Leigh Ann Vaughan, Catherine Lucid, Sharon Sims, Brian Engelhardt, MD, Wichai Chinratanalab, MD, Adetola A. Kassim, MD, MS, Stacey Goodman, MD, John P. Greer, MD, Friedrich Schuening, MD, Madan Jagasia, MD, MS, Bipin N. Savani, MD
Journal: Blood
Blood (2009) 114 (22): 3330.
https://doi.org/10.1182/blood.V114.22.3330.3330
Published: 2009